The FDA is considering expanding approval of Hympavzi to cover all people with hemophilia A or B ages 6 and older.
When a baby is diagnosed with hemophilia, their mother shouldn't be the only relative tested for it, argues columnist G Shellye Horowitz.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results